Prise en charge des céphalées secondaires aux hémorragies sous-arachnoïdiennes dans les centres de neurochirurgie français

Binhas, M.; Walleck, P.; Bitar, Nabil El; Melon, E; Palfi, Stéphane; Albaladéjo, Pierre; Marty, J.

doi:10.1016/j.annfar.2006.05.001

Cited by 12 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moderate pain was reported during the first week after admission; median (interquartile range) maximum NPRS scores on days 1 to 7 were 5 (4, 7), 5 (3,6), 5 (3,6), 5 (3,6), 5 (3, 7), 5 (3,7), and 4 (2,6), respectively; NPRS peaked on day 5 and progressively decreased thereafter (Supplemental Digital Content 3: Daily maximum and mean NPRS score, http://links.lww.com/JNA/A504). Thirty-six (56.25%) patients experienced at least 1 episode of severe pain.…”

Section: Course Of Headaches and Analgesia Requirementsmentioning

confidence: 99%

“…Opioid use is restricted in patients with altered levels of consciousness since it may impair the detection of sSAH-related complications. There is also a theoretical restriction to the use of nonsteroidal anti-inflammatory drugs because of the potential for increased bleeding risk in a situation where emergency neurosurgical procedures might be required 1–3. Together, these restrictions demonstrate how challenging the management of sSAH-related headaches can be.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Course of Headaches and Predictive Factors Associated With Analgesia Failure Following Spontaneous Subarachnoid Hemorrhage: A Prospective Cohort Study

Bouchier

Demarquay

Dailler

et al. 2022

Journal of Neurosurgical Anesthesiology

View full text Add to dashboard Cite

Background: Headache is the most common presenting symptom of spontaneous subarachnoid hemorrhage and managing this acute pain can be challenging. The aim of this study was to describe the course of headaches and factors associated with analgesic failure in patients with spontaneous subarachnoid hemorrhage. Methods: We conducted a prospective observational study in patients admitted to a neurocritical care unit (between April 2016 and March 2017) within 48 hours of spontaneous subarachnoid hemorrhage. Headache intensity was assessed using a Numerical Pain Rating Scale (NPRS) ranging from 0 to 10. Analgesic failure was defined as any day average NPRS score >3 after 72 hours of hospitalization despite analgesic treatment. Results: Sixty-three patients were included in the analysis. Thirty-six (56.25%) patients experienced at least 1 episode of severe headache (NPRS ≥7), and 40 (63.5%) patients still reported moderate to severe headache on the final day of the study (day 12). Forty-six (73.0%) patients required treatment with opioids and 37 (58.7%) experienced analgesic failure. Multivariable analysis showed that analgesic failure was associated with smoking history (odds ratio [OR]=4.31, 95% confidence interval [CI]: 1.23-17.07; P=0.027), subarachnoid blood load (OR=1.11, 95% CI: 1.01-1.24; P=0.032) and secondary complications, including rebleeding, hydrocephalus, delayed cerebral ischemia, hyponatremia, or death (OR=4.06, 95% CI: 1.17-15.77; P=0.032). Conclusions: Headaches following spontaneous subarachnoid hemorrhage are severe and persist during hospitalization despite standard pain-reducing strategies. We identified risk factors for analgesic failure in this population.

show abstract